Haymond, Morey W., and Agneta L. Sunehag. The reciprocal pool model for the measurement of gluconeogenesis by use of [U-13 C]glucose. Am. J. Physiol. Endocrinol. Metab. 278: E140-E145, 2000.-To improve upon the [U-13 C]glucose method to estimate ''gluconeogenesis'' as described by J. J. A. Tayek (Am. J. Physiol. Endocrinol. Metab. 272: E476-E484, 1997, and 275: E537-E542, 1998), we describe the reciprocal pool model by using only the isotopomer data of plasma glucose during infusion of [U-13 C]glucose. The glucose pool serves as both precursor and product for the calculation of the fraction of molecules generated by gluconeogenesis and to correct for exchange and loss of labeled carbon at the level of the tricarboxylic acid cycle. We have applied this model to both our own data and those of other investigators using [U- 13 O-glucose-C-5), the results are similar in short-and long-term fasted adult humans. Finally, when we apply the reciprocal pool model to our data from premature infants, it is clear that we account for the inflow of unlabeled glycerol and presumably amino acids. This is not surprising, because the vast majority of gluconeogenesis is the result of recycling of glucose and pyruvate carbon. glucose metabolism; mass isotopomer distribution analysis; stable isotopes THE SYNTHESIS OF GLUCOSE via gluconeogenesis is complicated by our inability to sample the true precursor pool(s) (i.e., isotopic enrichment and the distribution of label in the three carbon units at the level of the triose phosphates) and to know the degree of isotopic exchange that occurs as substrate is processed through glycolysis, the tricarboxylic acid (TCA) cycle, and gluconeogenesis. Over the past several years, three new and independent methods have been developed to estimate the fraction of glucose production derived from gluconeogenesis in vivo (5-8, 10, 11, 14, 23). Each has its own unique strengths (and weaknesses), but each also relies on plausible assumptions that are not directly verifiable in vivo.
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J. Katz and J. A. Tayek (8, 23) have proposed a method employing the infusion of [U- 13 C]glucose and the measurement of the isotopomer distribution of 13 C in glucose. Gluconeogenesis is calculated as the product of the fraction of glucose molecules generated via gluconeogenesis and a correction factor. The latter is the ratio of all 13 C atoms in glucose to all 13 C atoms in plasma lactate (8, 23) . Much controversy has surrounded the application of this method to in vivo studies (8, 12, 21) .
We present an alternative model for the analysis of the glucose isotopomer information obtained during infusion of [U- 13 C] glucose. This model builds on that proposed by Katz and Tayek (8, 23) . However, we have derived the equations employed and use the isotopomer information in the plasma glucose pool to calculate the molecules generated by gluconeogenesis and to correct for loss and exchange of labeled carbon at the level of the TCA cycle. Thus the analytical problems and assumptions associated with the use of the lactate measurements are avoided. The assumptions of our approach are straightforward, and the resultant calculations are simplified, as is the analytical work required. We have utilized our own data, as well as those from the literature, to explore the validity of this new approach.
THE RECIPROCAL POOL MODEL
Assumptions of the Model 1) Labeled and unlabeled glucose are metabolized identically, i.e., there is no isotope discrimination.
2) During infusion of [U- 13 C]glucose at a constant rate, substrate and isotopomer steady state is approximated.
3) Entry and exit of labeled glucose from hepatic glycogen are equal and constant.
4) The only source of [ 13 C 6 ] glucose is from the exogenous infusion of tracer, i.e., the probability of a [ 13 C 6 ]glucose being formed from two 13 C 3 molecules at the triose phosphate level of gluconeogenesis is negligible.
5) Accurate measurement of all isotopomers can be made and appropriately corrected for natural abundance and the isotopomer distribution of the infused tracer.
6) 13 CO 2 fixation is assumed to be negligible unless
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Definitions 1)
Unlabeled glucose molecules ( 12 C 6 ) are denoted M 0 , glucose molecules with one 13 C and five 12 C in any position ( 13 C 1 12 C 5 ) are denoted M 1 , glucose molecules with two 13 C and four 12 C in any position ( 13 C 2 12 C 4 ), M 2 , and so on. Glucose molecules uniformly labeled with 13 C ( 13 C 6 ) are denoted M 6 .
2) The enrichment (E Mi ) of any glucose species (M 1 through M 6 ) is the mole ratio (R) for each species corrected for the isotopic contribution of natural abundance and the distribution of the isotopomers in the tracer, divided by the sum of all other glucose species (including the fraction of M 0 denoted F M0 ), that is
where i is the number of 13 C in each species of glucose.
PRODUCT/PRECURSOR RELATIONSHIP
The primary precursor for all labeled species of glucose is infused [U-13 C]glucose. During the course of a constant infusion of this tracer, labeled species of glucose appear in the plasma glucose pool as M 1 . . .M 5 isotopomers. These species can only be derived as the result of return of tracer 13 C atoms via the gluconeogenic process. However, once entering the glucose pool, each of these labeled species of glucose, i.e., M 1 . . .M 6 , will serve as a source of 13 C from which new glucose can be labeled. Thus the M 1 . . .M 5 species are labeled products of gluconeogenesis, and the M 1 . . .M 6 species represent the labeled precursors.
RATE OF ENTRY OF UNLABELED AND LABELED SPECIES OF GLUCOSE
The entry of each species of glucose (rate of appearance, R a ) can be calculated using the following standard formula R a, total ϭ [U- Therefore, the fraction of all of the labeled species of glucose derived from gluconeogenesis is (To save space, in the examples and tables this equation is written:
CORRECTION FACTOR FOR LOSS OF LABEL
The fraction of labeled species derived from gluconeogenesis shown above, however, does not take into account the loss and exchange of labeled carbon for unlabeled carbon at the level of oxaloacetate. Each labeled glucose molecule (M 1 . . .M 5 ) is the result of the condensation of two three-carbon molecules (triose phosphates), of which at least one contains 13 C. Therefore, the distribution of labeled and unlabeled carbon in the M 1 . . .M 5 glucose species reflects the isotopomer distribution of the labeled and unlabeled carbons in the glyceraldehyde-3-phosphate and the dihydroxyacetone phosphate pools. Were there no exchange as a result of the enzymatic events that occur in the TCA cycle, only M 3 species of glucose would be derived via gluconeogenesis from the [U-13 C]glucose tracer, and the number of 12 C and 13 C atoms in labeled glucose molecules derived from gluconeogenesis would be equal, i.e., 12 C/ 13 C ϭ 1.0. This does not occur. Some of the 13 C from labeled pyruvate (generated from M 1 -M 6 species of glucose) will be lost as a result of carbon exchange and oxidation in the TCA cycle. This will result in a total loss of 13 C in some phosphoenolpyruvate (PEP) molecules generated from labeled pyruvate. Conversely, 12 C will be gained as a result of the entry of unlabeled substrates (lactate, alanine, glycerol, and glutamine) with their subsequent randomization and exchange in the TCA cycle. Collectively, these processes will result in an underestimation of the fraction of glucose derived from gluconeogenesis, a process early appreciated by Dr. Krebs (9) as the essential issue in quantifying gluconeogenesis by use of a tracer.
Thus, during infusion of [U-13 C]glucose tracer, all labeled carbon in glucose comes directly or indirectly from this tracer, but those glucose species containing fewer than three labeled carbons reflect replacement of a labeled carbon by an unlabeled carbon due to loss and exchange. For this reason, the ratio of 12 C-to 13 Clabeled M 1 -M 5 glucose molecules is an index of this loss of labeled carbon. The loss of label is reflected in the relative entry rates (R a ) of 13 C and 12 C in glucose generated via gluconeogenesis. Thus the R a of the 12 C and 13 C in each of the M 1 -M 5 species of glucose can be calculated in a fashion similar to that just described for labeled glucose species with the following formulas
where i is 1-5 and represents the number of 13 C in each species of glucose. Thus the ratio of entry rates of the 12 C and 13 C carbons in the glucose species labeled as a result of the process of gluconeogenesis (M 1 . . .M 5 ) is the ratio of the sums of the entry rates of the 12 C and 13 C in M 1 . . .M 5 species, respectively, or [In the examples and tables, this equation is written:
Consequently, the fraction of circulating glucose derived from gluconeogenesis, including the correction for loss of label, is the product of the fraction of labeled molecules derived via gluconeogenesis and the ratio of 12 C to 13 C in these molecules 5In the examples and tables, this equation is written:
In the examples and tables that follow, gluconeogenic rate ϭ fractional gluconeogenesis ϫ glucose R a . Gluconeogenesis (GNG) as a fraction of glucose production rate (GPR) ϭ gluconeogenic rate/GPR, where GPR ϭ glucose R a Ϫ any exogenously infused glucose.
APPLICATION OF THE RECIPROCAL POOL MODEL TO PUBLISHED DATA
In the examples below, we have used our own data (21) , as well as data published by other investigators (12) , to explore in detail each step in the proposed model. The calculations are based on the average isotopomer values from these publications.
Example 1
In this first example, premature infants (n ϭ 8) received [U-13 C]glucose (93.5% 13 C 6 ) over 10 h at a rate of 16.7 µmol · kg Ϫ1 · min Ϫ1 [as part of total parenteral nutrition that also includes lipids and amino acids (21) ]. The [U- 13 C]glucose represented the total amount of exogenous glucose delivered and is an extreme of isotope administration.
* ''As Published'' values represent calculations performed according to Katz and Tayek (8, 23) , i.e., the correction for loss of labeled carbon was based on lactate data (8, 23) . † In this example, about one-half of the glucose R a was provided exogenously as [U-13 C]glucose, and gluconeogenesis as a fraction of GPR was calculated by dividing the gluconeogenic rate by the GPR.
Example 2
In this study, healthy adults (n ϭ 3) were studied after a 65-h fast. [U- 13 C] glucose was infused at a low rate of 0.4 µmol · kg Ϫ1 · min Ϫ1 over 5-6 h (12).
[U- The published data are based on the ''corrected'' equation as described by Landau et al. (12) , which does not include any correction factor for loss of labeled carbon, resulting in a value for gluconeogenesis that is about one-half that obtained by both the Tayek and Katz method (8, 23 ) and the proposed reciprocal pool model.
DISCUSSION
The proposed model significantly simplifies that of Katz and Tayek (8, 23) in that only the isotopomer analysis of glucose needs to be made; e.g., analysis of plasma lactate is not necessary. Thus the entire calculation of gluconeogenesis is made on the basis of 1) a product/precursor relationship and 2) a correction factor. This factor corrects for loss and exchange of labeled carbon on the basis of the ratio of 12 C to 13 C in the labeled glucose molecules derived from gluconeogenesis (M 1 -M 5 ), not from circulating lactate (8, 23) or from an indirect estimate of the enrichment at the level of the triose phosphates (6) .
The concept that M 1 through M 5 glucose molecules can only be generated via gluconeogenesis is clear. However, the correction for exchange and loss of labeled carbon is more difficult. It is impossible to know the precise locations of each of these labels in the M 1 -M 5 species of glucose, and tracing the precursors through the myriad of potential metabolic pathways (e.g., carboxylations, decarboxylations, and rearrangements) becomes futile when one understands that the precursor is product and the product is precursor. However, exchange and loss of labeled carbon do occur and result in an increase in the 12 C-to- 13 C ratio in the M 1 -M 5 glucose and an underestimation of gluconeogenesis. The described correction factor compensates for this loss.
It is of interest to note that the correction factor calculated using the reciprocal pool model is very similar to that derived from the isotopomer distribution of plasma lactate and glucose as described by Katz and Tayek (8, 23) (Table 1) . Some of the differences observed in the correction factors (Table 1) could, in part, be due to the low infusion rates of [U- 13 C]glucose employed in these studies, resulting in low enrichments of M 1 through M 3 in plasma glucose and of m 1 through m 3 in lactate (12, 23) . In our opinion, the measurement of the enrichments of molecular species below the level of 0.7-0.8% is associated with potential inaccuracies. Fortunately, the price of [U- 13 C]glucose has decreased dramatically over the past 2 yr, making such studies in adult humans only expensive, not financially impossible. Therefore, the investigator must weigh the potential confounding variables of an infusion of a nearsubstrate amount of tracer (i.e., up to 10-15% enrichment in the M 6 ), which will result in more accurate and reproducible measurement of all glucose isotopomers, vs. potential errors associated with low enrichments of all glucose isotopomers due to a lower rate of tracer infusion. addition, these estimates of gluconeogenesis are similar to those obtained after comparable periods of fasting, in which the methods of Hellerstein et al. (6) and Landau et al. (11) were used ( Table 3 ). This is remarkable, considering that these results are derived from different laboratories and follow different periods of isotope infusion at different enrichments of tracer. Whether our model, or any of the other proposed models, measures absolute rates of gluconeogenesis, pure Cori cycle activity, or some value in between, remains to be determined, because no ''gold standard'' exists to which the results of these models can be compared. The events regulating the delivery of metabolic precursors and the myriad of potential pathways and futile cycles through which substrate and label might pass make the modeling of this process intellectually intriguing but not necessarily enlightening. The major concern of the opponents of the Katz and Tayek method, and most likely our approach as well, is whether this method measures the influx of unlabeled gluconeogenic precursors derived from proteolysis and lipolysis, i.e., amino acids and glycerol.
Of the potential gluconeogenic amino acids, it is generally accepted that alanine and glutamine are the most important and account for ϳ10% of total glucose R a after an overnight fast (2, 3, 17) . About 65-80% of alanine and 80% of glutamine turnover are derived via de novo synthesis (1, 4, 17, 19) . Isotope labeling studies have demonstrated that 65% of alanine is derived from pyruvate (1) and that infusion of glucose at 4 mg·kg Ϫ1 · min Ϫ1 is associated with a 40% increase in de novo synthesis of alanine (19) . In addition, glucose infusion at a similar rate doubled the contribution of glucose carbon to glutamine (R. G. Hankard, M. W. Haymond, and D. Darmaun, unpublished data). Thus a significant portion of alanine and glutamine carbon is derived from glucose via pyruvate and will result in a progressive labeling of these precursor pools for gluconeogenesis.
Glycerol derived from the hydrolysis of triglycerides contributes ϳ3-5% of glucose R a in the postabsorptive state and 10-15% in the prolonged fasting state (13, 18, 24) . Landau et al. (13) recently reported data from 60-h-fasted humans demonstrating that a maximum of 38% of [U- 13 C]glycerol is converted directly to glucose (Mϩ3), whereas 35% of glycerol label entered glucose ( 14 C-1, 14 C-4, and 14 C-6) via pyruvate (13) . We presume that the remaining 27% is lost via oxidation. Therefore, some 62% (35% ϩ 27%) of glycerol derived from lipolysis (together with alanine and glutamine) passes through the pyruvate pool and may be labeled as a result of isotope exchange during infusion of [U- 13 C]glucose. However, unlabeled lactate, alanine, glycerol, and glutamine provide 12 C atoms that enter the TCA cycle and are involved in the randomization and exchange of carbons, possibly resulting in an underestimation of gluconeogenesis.
We recently demonstrated that the [2-13 C]glycerol and [U-13 C]glucose methods provided similar estimates of gluconeogenesis in premature infants studied under nearly identical conditions (21) . The C-6 deuterium method, which does not include the contribution of glycerol, provided an estimate that was Ͻ30% of estimates obtained using the other two methods. However, when the contribution of glycerol to gluconeogenesis measured by the [2-13 C]glycerol method is added to that of the C-6 deuterium method, the resultant value is similar to values obtained with the [2-13 C]glycerol and the [U- 13 C]glucose methods (21) . Applying our reciprocal pool model to these data leads to similar results (Fig. 1) . Were our method and that of Katz and Tayek unable to measure the contribution of glycerol to gluconeogenesis, we would have observed a result similar to that of the C-6 deuterium method alone, but this was not the case. Therefore, we conclude that our model, as well as that of Katz and Tayek, accounts for at least the majority of the contribution of glycerol to gluconeogenesis. This is not at all surprising in that, as discussed above, the vast majority of glucose production derived from gluconeogenesis is the result of recycling of pyruvate (i.e., Cori cycle activity). The objective facts speak for themselves.
The reciprocal pool model is uniquely internal to itself and makes no assumptions or extrapolations as to the ''true'' precursor pool at the level of the triose phosphates and is analytically much simpler than the Fig. 1 . Gluconeogenic rate in three comparable groups of premature infants receiving total parenteral nutrition (21) determined by [U- 13 C]glucose, by use of the reciprocal pool, the [2-13 C]glycerol (5, 6) , and the 2 H 2 O-glucose-C-6 methods (7). * Contribution from glycerol as measured by the [2-13 C]glycerol method was added to the 2 H 2 Oglucose-C-6 estimate (which does not include the glycerol contribution).
2 H 2 O method, with measurement of the deuterium enrichment at the C-2 and C-5 positions of glucose. It is, however, important to recognize that each of the fundamental methods to estimate ''gluconeogenesis'' has its unique strengths and weaknesses, and only through continued exploration of the models and the substrate and hormone factors that regulate gluconeogenesis will we gain further insights into these and perhaps other models to measure gluconeogenesis. We should not permit the present controversy regarding methodology to inhibit the progress in exploring the factors that regulate gluconeogenesis in humans.
